Gynecologic Oncology Research and Practice operates a single-blind peer-review system where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts are assigned to one of the Editors-in-Chief and after an initial screening for general suitability, manuscripts are reviewed by two or more experts in the field. Reviewers are asked to evaluate whether the manuscript is scientifically sound and coherent and whether the manuscript should be accepted, rejected or revised. Final decisions rest with the Editors-in-Chief.
Edited by Robert L Coleman, Thomas J Herzog and Bradley J Monk, Gynecologic Oncology Research and Practice is supported by an expert Editorial Board.
2017 Journal Metrics
59 days to first decision for reviewed manuscripts only
60 days to first decision for all manuscripts
89 days from submission to acceptance
14 days from acceptance to publication
54 Altmetric Mentions